The competition brief for the next Cancer Innovation Challenge funding competition has been launched. The competition will be to find Innovative data science solutions to improve cancer care and outcomes in Scotland. Organisations in the EU can apply for a share of £425,000 through a two phase funding competition.
The application process opened on Friday 8 September. Potential bidders will need to register their interest by 27 October 2017 to get access to the competition documents and their final applications will need to be submitted by 10 November 2017.
Interested applicants can register to attend an Information Session and Collider Event on 12 October 2017.
This funding competition is not just for organisations already working in the healthcare sector. The Cancer Innovation Challenge is looking for innovation from any organisations with experience of working with large complex, heterogeneous datasets in a safe environment.
This is an opportunity for companies to make a real difference to the lives of cancer patients in Scotland!
Please visit the competition page for further information.
The launch of this second competition comes just days after the first five Cancer Innovation Challenge funded projects were officially announced. The five projects were successfully awarded funding in Phase 1 of the first Cancer Innovation Challenge SBRI funding competition looking for New approaches to record and integrate cancer PROMs (patient recorded outcome measures) and PREMs (patient recorded experience measures).
The five companies behind the projects are:
Docobo Ltd, Surrey
My Clinical Outcomes Ltd, London
Px HealthCare Ltd, London
Sitekit Health Ltd, Isle of Skye
The companies have been funded up to £25k each to undertake a 3 month feasibility study for their proposed digital healthcare solution. At the end of the three months, they will be invited to apply for a further £100k each to take their project on to a 6 month development and evaluation period in Phase 2. Up to 2 companies will be successfull in progressing to Phase 2.
A launch event and stakeholder engagement workshop took place last week in Edinburgh where the companies had an opportunity to engage with various relevant stakeholders including patient representatives, clinicians, academics, NHS innovation and NHS eHealth staff and discuss key issues and challenges they may face.
Find out more about the five projects here.